NASDAQ:DBVT
DBV Technologies S.A. Stock News
$0.667
-0.0031 (-0.463%)
At Close: May 03, 2024
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
04:30pm, Friday, 29'th Jan 2021
AMF REGULATED INFORMATION Montrouge, France, January 29, 2021
Why DBV Technologies Stock Popped Today
11:56am, Friday, 15'th Jan 2021
After hitting a major regulatory roadblock, DBV Technologies sees a path to approval for its leading candidate.
DBVT Stock: DBV Technologies Soars on Big Peanut Allergy Patch News
11:23am, Friday, 15'th Jan 2021
DBV Technologies (DBVT) stock is soaring higher on Friday after providing an update on its upcoming peanut allergy treatment. The post DBVT Stock: DBV Technologies Soars on Big Peanut Allergy Patch Ne
DBV Technologies Provides Update on Investigational Viaskin™ Peanut for Children Ages 4-11 Years
04:30pm, Thursday, 14'th Jan 2021
Montrouge, France, January 14, 2020
Monthly information regarding the total number of voting rights and total number of shares of the Company as of December 31, 2020
04:30pm, Tuesday, 05'th Jan 2021
Monthly information regarding the total number of voting rights and
Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2020
04:30pm, Tuesday, 15'th Dec 2020
Monthly information regarding the total number of voting rights and total number of shares of the Company as of November 30, 2020
Monthly information regarding the total number of voting rights and total number of shares of the Company as of October 31, 2020
04:30am, Wednesday, 11'th Nov 2020
Monthly information regarding the total number of voting rights and
DBV Technologies to Highlight Data on Viaskin™ Peanut Treatment Delivery and Patient Experience at ACAAI 2020
01:30am, Tuesday, 10'th Nov 2020
Montrouge, France, November 10, 2020 DBV Technologies to Highlight Data on Viaskin ™ Peanut Treatment Delivery and Patient Experience at ACAAI 2020
DBV Technologies to Participate in Upcoming Investor Conferences
01:30am, Monday, 09'th Nov 2020
Montrouge, France, November 9, 2020 DBV Technologies to Participate in Upcoming Investor Conferences
Why DBV Technologies Stock Is Soaring Today
12:31pm, Monday, 02'nd Nov 2020
The company submitted its potential peanut allergy treatment for review in Europe.
Is This Peanut Allergy Treatment Back on the Table?
10:49am, Monday, 02'nd Nov 2020
DBV Technologies S.A. (NASDAQ: DBVT) shares absolutely exploded on Monday after the firm announced that the Marketing Authorization Application (MAA) for its peanut allergy treatment was validated by
Montrouge, France, November 2, 2020
DBV Technologies Reports September 30, 2020 Cash Position
02:30am, Friday, 30'th Oct 2020
Montrouge, France, October 30, 2020
Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2020
08:01pm, Wednesday, 12'th Aug 2020
Monthly information regarding the total number of voting rights and total number of shares of the Company as of July 31, 2020(Article 223-16 of the General Regulations of the Autorité des Marchés
Could This Small-Cap Biotech Stock Make You Rich?
02:59pm, Tuesday, 11'th Aug 2020
Thanks to bad news for its competitor, this company behind the first FDA-approved peanut allergy treatment could be ripe for a rebound.
